Drug: tocilizumab Quarter: 2016Q3
Total Drug/Injury Combinations: 356 Number of Pages: 18
DRUGNAME | PT | EventCount | |
---|---|---|---|
Tocilizumab | Syncope | 1 | view events |
Tocilizumab | T-cell type acute leukaemia | 1 | view events |
Tocilizumab | Tachyarrhythmia | 1 | view events |
Tocilizumab | Tachycardia | 1 | view events |
Tocilizumab | Thyroid cyst | 1 | view events |
Tocilizumab | Tibia fracture | 1 | view events |
TOCILIZUMAB | Tuberculosis of central nervous system | 1 | view events |
tocilizumab | Tumour lysis syndrome | 1 | view events |
Tocilizumab | Upper gastrointestinal haemorrhage | 1 | view events |
Tocilizumab | Uterine leiomyoma | 1 | view events |
TOCILIZUMAB | Vaginal infection | 1 | view events |
TOCILIZUMAB | Varicella zoster virus infection | 1 | view events |
Tocilizumab | Venous thrombosis | 1 | view events |
Tocilizumab | Vertigo | 1 | view events |
Tocilizumab | Vitamin D deficiency | 1 | view events |
Tocilizumab | Wrist surgery | 1 | view events |
Total Drug/Injury Combinations: 356 Number of Pages: 18
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)